This advisory notice has been issued by the HSE National Clinical Lead for Addiction Services to notify service providers of the on-going risk of counterfeit benzodiazepines containing new psychoactive substances (NPS).NPS or new types of benzodiazepines appearing on the market are of particular concern due to the high potency of these substances even at lowContinue reading “HSE Emerging Drug Trend Advisory Notification…”